13.36
price up icon0.68%   0.09
pre-market  Vorhandelsmarkt:  13.20   -0.16   -1.20%
loading
Schlusskurs vom Vortag:
$13.27
Offen:
$13.16
24-Stunden-Volumen:
151.38K
Relative Volume:
1.26
Marktkapitalisierung:
$4.03B
Einnahmen:
$391.87M
Nettoeinkommen (Verlust:
$-441.45M
KGV:
-7.2216
EPS:
-1.85
Netto-Cashflow:
$-301.21M
1W Leistung:
+0.38%
1M Leistung:
+12.17%
6M Leistung:
+11.89%
1J Leistung:
-5.52%
1-Tages-Spanne:
Value
$13.05
$13.44
1-Wochen-Bereich:
Value
$13.05
$13.50
52-Wochen-Spanne:
Value
$9.15
$18.00

Alvotech Stock (ALVO) Company Profile

Name
Firmenname
Alvotech
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
999
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-13
Name
Neueste SEC-Einreichungen
Name
ALVO's Discussions on Twitter

Vergleichen Sie ALVO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ALVO
Alvotech
13.36 4.03B 391.87M -441.45M -301.21M -1.85
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
167.53 75.58B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.24 41.78B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.10 41.53B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
21.82 24.72B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
145.88 14.77B 2.24B 385.90M 440.10M 3.73

Alvotech Stock (ALVO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-01-29 Hochstufung Barclays Equal Weight → Overweight
2023-10-20 Hochstufung Citigroup Sell → Neutral
2023-09-21 Eingeleitet Barclays Equal Weight
2022-09-07 Eingeleitet Morgan Stanley Equal-Weight
2022-09-06 Herabstufung Citigroup Buy → Sell
2022-07-26 Eingeleitet Citigroup Buy
Alle ansehen

Alvotech Aktie (ALVO) Neueste Nachrichten

pulisher
Jan 17, 2025

JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Jan 17, 2025
pulisher
Jan 17, 2025

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 17, 2025
pulisher
Jan 15, 2025

Alvotech : Transactions of Managers and Closely Associated Persons - Marketscreener.com

Jan 15, 2025
pulisher
Jan 15, 2025

Has Alvotech (ALVO) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Jan 15, 2025
pulisher
Jan 13, 2025

Alvotech (NASDAQ:ALVO) Sees Large Growth in Short Interest - MarketBeat

Jan 13, 2025
pulisher
Jan 08, 2025

Alvotech (NASDAQ:ALVO) Shares Gap UpWhat's Next? - MarketBeat

Jan 08, 2025
pulisher
Jan 03, 2025

Alvotech birtir fjárhagsdagatal fyrir árið 2025 - GlobeNewswire

Jan 03, 2025
pulisher
Jan 02, 2025

Alvotech Eyes Growth As Product Revenue Soars And New Launches ApproachWill The Stock Follow? - RTTNews

Jan 02, 2025
pulisher
Dec 30, 2024

Are Medical Stocks Lagging Alvotech (ALVO) This Year? - Yahoo Finance

Dec 30, 2024
pulisher
Dec 28, 2024

Alvotech (NASDAQ:ALVO) Short Interest Update - MarketBeat

Dec 28, 2024
pulisher
Dec 23, 2024

Alvotech Joins Nasdaq Biotechnology Index, Boosting Industry Presence - TipRanks

Dec 23, 2024
pulisher
Dec 23, 2024

Alvotech : Added to Nasdaq Biotech Index Effective Monday December 23, 2024 Form 6 K - Marketscreener.com

Dec 23, 2024
pulisher
Dec 23, 2024

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024 - The Manila Times

Dec 23, 2024
pulisher
Dec 23, 2024

Alvotech Secures Coveted Spot in Nasdaq Biotechnology Index Following Strong Market Performance - StockTitan

Dec 23, 2024
pulisher
Dec 20, 2024

ALVOAlvotech Ordinary Shares Latest Stock News & Market Updates - StockTitan

Dec 20, 2024
pulisher
Dec 18, 2024

Wall Street Analysts Believe Alvotech (ALVO) Could Rally 39.83%: Here's is How to Trade - MSN

Dec 18, 2024
pulisher
Dec 15, 2024

Alvotech's SWOT analysis: biosimilar powerhouse stock faces b2b model challenges - Investing.com

Dec 15, 2024
pulisher
Dec 13, 2024

Is Alvotech (ALVO) Stock Outpacing Its Medical Peers This Year? - MSN

Dec 13, 2024
pulisher
Dec 10, 2024

Eye on Pharma: Golimumab Biosimilar Update; Korea Approves Denosumab; Xbrane, Intas Collaboration - The Center for Biosimilars

Dec 10, 2024
pulisher
Dec 03, 2024

Alvotech (NASDAQ:ALVO) Is Expected To Breakeven In The Near Future - Simply Wall St

Dec 03, 2024
pulisher
Nov 30, 2024

Short Interest in Alvotech (NASDAQ:ALVO) Rises By 47.8% - MarketBeat

Nov 30, 2024
pulisher
Nov 26, 2024

Alvotech’s Eylea Biosimilar ‘Keeps In Mind’ US Patent Landscape - Citeline

Nov 26, 2024
pulisher
Nov 25, 2024

Alvotech's SWOT analysis: biosimilars powerhouse stock faces growth hurdles - Investing.com

Nov 25, 2024
pulisher
Nov 22, 2024

Alvotech (ALVO) Shares Gap Down to $11.94 on Nov 22 - GuruFocus.com

Nov 22, 2024
pulisher
Nov 21, 2024

Alvotech’s Position In The Coming Biosimilar Gold Rush (NASDAQ:ALVO) - Seeking Alpha

Nov 21, 2024
pulisher
Nov 20, 2024

Alvotech (ALVO) Q3 Earnings and Revenues Beat Estimates - MSN

Nov 20, 2024
pulisher
Nov 16, 2024

Alvotech Third Quarter 2024 Earnings: US$0.041 loss per share (vs US$0.81 loss in 3Q 2023) - Yahoo Finance

Nov 16, 2024
pulisher
Nov 15, 2024

Earnings call: Alvotech reported revenues of $128 million - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Alvotech (ALVO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements - Investing.com Canada

Nov 15, 2024
pulisher
Nov 14, 2024

Alvotech Reports Strong Revenue Growth in 2024 - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Earnings call: Alvotech reported revenues of $128 million By Investing.com - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

Alvotech earnings missed, revenue fell short of estimates By Investing.com - Investing.com Nigeria

Nov 14, 2024
pulisher
Nov 14, 2024

Alvotech earnings missed, revenue fell short of estimates - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Alvotech's SWOT analysis: biosimilars powerhouse stock faces growth challenges By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 13, 2024

Alvotech : First 9 Months Earnings and Business Update 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Alvotech Showcases Strong Financial Growth and Expansion - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Alvotech Reports Financial Results for the First Nine Months of 2024 - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Alvotech's SWOT analysis: biosimilars powerhouse stock faces growth challenges - Investing.com

Nov 13, 2024
pulisher
Nov 07, 2024

EMA Accepts Marketing Authorization Application for Alvotech’s AVT05 (golimumab) - JD Supra

Nov 07, 2024
pulisher
Nov 07, 2024

Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore's HealthCONx Conference on December 5, 2024 - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Alvotech Attending Citi's Global Healthcare Conference on - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Alvotech to Present at Citi and Evercore Healthcare Conferences in December | ALVO Stock News - StockTitan

Nov 07, 2024

Finanzdaten der Alvotech-Aktie (ALVO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$30.10
price up icon 2.14%
$12.04
price up icon 0.17%
$94.05
price up icon 2.82%
$126.50
price up icon 0.24%
$11.33
price up icon 0.27%
$145.88
price up icon 1.83%
Kapitalisierung:     |  Volumen (24h):